CONCORDIA ANNOUNCES MERCK AS A 2021 PATRON SPONSOR

Concordia is proud to continue its partnership with Merck & Co., Inc. (known as MSD outside of the US and Canada) as a 2021 Annual Summit Patron Sponsor.

For 130 years, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases, such as HIV and Ebola, in pursuit of saving and improving lives. Today, Merck aspires to be one of the world’s premier research-intensive biopharmaceutical companies. 

“As global healthcare systems are transformed as a result of COVID-19, Merck’s research-focused approach and commitment to providing global access to medicines and vaccines sets a leading example,” commented Concordia’s Co-Founder & CEO, Matthew Swift. “Concordia and Merck believe in a collective approach to transforming the global healthcare space, and we’re thrilled to be continuing our partnership.”

As a Programming Sponsor at the 2020 Annual Summit, Merck led the Addressing AMR panel, which explored the importance of aligning the public and private sectors to address the global challenge of antimicrobial resistance (AMR). In alignment with Concordia’s Health Disparities, Recovery & Resilience programming theme at this year’s Annual Summit, Merck will host a Main Stage session that will highlight the company’s revolutionary efforts to combat rising levels of AMR and its commitment to developing an effective response to the COVID-19 pandemic since it was first recognized. 

To learn more about Merck and its work in the global healthcare sector, click here.